Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)

Drug repurposing for COVID-19 has several potential benefits including shorter development time, reduced costs and regulatory support for faster time to market for treatment that can alleviate the current pandemic. The current study used molecular docking, molecular dynamics and protein-protein inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Egieyeh, Samuel, Egieyeh, Elizabeth, Malan, Sarel, Christofells, Alan, Fielding, Burtram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793299/
https://www.ncbi.nlm.nih.gov/pubmed/33417604
http://dx.doi.org/10.1371/journal.pone.0245258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793299/
https://www.ncbi.nlm.nih.gov/pubmed/33417604
http://dx.doi.org/10.1371/journal.pone.0245258

Ejemplares similares